The results of a new study show the rate of colon cancer death in the United States for people with low socioeconomic status increased between 1980 and 2008 while it decreased during the same period ...

A new study has found evidence linking the use of GLP-1 medications like Ozempic and Wegovy to lower death rates in colon cancer patients. The University of California, San Diego study examined data ...

A new study now shows more younger people are developing and dying from colorectal cancers. The study, published in the Journal of the American Medical Association, found that more white Americans ...

Deaths from cancer have declined by 33% since 1991, averting 4.1 million deaths. However, more people are being diagnosed with cancer than ever before, and at an earlier age, according to a major new ...

Colon cancer is on the rise among young adults — with more people in their 40s, 30s, and even 20s being diagnosed. In fact, colon cancer is the leading cause of cancer death in men under 50 and the ...

Cases of colorectal cancer in younger adults are climbing worldwide, driven by lifestyle changes and inherited genetic risks. Diet, obesity, and lack of early screening are playing a major role in ...

Counties with the highest incarceration rates had 7% to 10% more deaths from lung, liver, and colorectal cancers. Counties with the highest rates of jail incarceration had significantly higher ...

A study finds that $100 rideshare rides for follow-up colonoscopy after fecal immunochemical test (FIT) doubled completion rates, reduced colorectal cancer (CRC) deaths, and lowered health care costs.

Weight-loss drugs have been found to dramatically slash death rates in colon cancer patients, according to new research. Patients taking GLP-1 receptors - the class of drugs behind Ozempic, Wegovy and ...

Here’s some gut-wrenching news. A troubling complication of colorectal cancer, the third-most common cancer in the US, is ...

Don’t stall — your butt is on the line. Because of this worrisome trend, the US Preventive Services Task Force (USPSTF) lowered its recommendation for starting colorectal cancer screening from age 50 ...